Ongoing results of a phase I trial of two sequential doses of Y-90 ibritumomab tiuxetan (Zevaline) for patients with relapsed low-grade non-Hodgkin lymphoma (NHL)

被引：0
|
作者：
Wiseman, G [1 ]
Geyer, S [1 ]
Porrata, L [1 ]
Inwards, D [1 ]
Colgan, J [1 ]
White, W [1 ]
Micallef, I [1 ]
Lacy, M [1 ]
Ansell, S [1 ]
Johnston, P [1 ]
Witzig, T [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
333
引用
收藏
页码：135 / 135
页数：1
相关论文
共 50 条
  • [1] Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma
    Gordon, LI
    Witzig, TE
    Wiseman, GA
    Flinn, IW
    Spies, SS
    Silverman, DH
    Emmanuolides, C
    Cripe, L
    Saleh, M
    Czuczman, MS
    Olejnik, T
    White, CA
    Grillo-López, AJ
    SEMINARS IN ONCOLOGY, 2002, 29 (01) : 87 - 92
  • [2] Cellular localization pattern of yttrium 90 (90Y) ibritumomab tiuxetan (Zevalin®) in a patient with low-grade non-Hodgkin's lymphoma (NHL).
    Jacobs, SA
    Harrison, AM
    Swerdlow, SH
    Foon, KA
    Avril, N
    Vidnovic, N
    McCarty, KS
    Saville, W
    BLOOD, 2004, 104 (11) : 226B - 226B
  • [3] Radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin®) is a safe and effective treatment option for older patients with relapsed or refractory low-grade non-Hodgkin's lymphoma (NHL)
    Meredith, R
    Schilder, RJ
    Emmanouilides, C
    Vo, K
    Witzig, TE
    Flinn, IW
    Darif, M
    Gordon, LI
    Molina, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S421 - S421
  • [4] Phase I trial of combination therapy with 90Y ibritumomab tiuxetan and gemcitabine in patients with non-Hodgkin is lymphoma.
    Borghaei, Hossein
    Smith, Mitchell
    Millenson, Michael
    Shafer, Danielle
    Thibodeau, Linda
    Schilder, Russell
    BLOOD, 2006, 108 (11) : 260B - 260B
  • [5] Safety of yttrium-90 ibritumomab tiuxetan radioimmunotherapy for relapsed low-grade, follicular, or transformed non-Hodgkin's lymphoma
    Witzig, TE
    White, CA
    Gordon, LI
    Wiseman, GA
    Emmanouilides, C
    Murray, JL
    Lister, J
    Multani, PS
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) : 1263 - 1270
  • [6] Phase I trial of combination therapy with 90Y ibritumomab tiuxetan (Zevalin) and gemicitabine in patients with non-hodgkin's lymphoma
    Borghaei, Hossein
    Smith, MitchellR.
    Millenson, Michael
    Thibodeau, Linda
    Kamiensky, Nicole
    Schilder, Russell J.
    BLOOD, 2007, 110 (11) : 192B - 193B
  • [7] Bortezomib May Be Safely Combined with Y-90 Ibritumomab Tiuxetan In Patients with Relapsed/Refractory Follicular or Transformed Non-Hodgkin Lymphoma: A Phase I Trial of Combined Induction Therapy and Bortezomib Consolidation
    Roy, Rupali
    Evens, Andrew M.
    Patton, David P.
    Larsen, Annette
    Rademaker, Alfred
    Cilley, Jeffrey
    Spies, Stewart
    Variakojis, Daina
    Gordon, Leo I.
    Winter, Jane N.
    BLOOD, 2010, 116 (21) : 730 - 730
  • [8] Radioimmunotherapy with 90Y ibritumomab tiuxetan in refractory/relapsed follicular non-hodgkin lymphoma results in an Spanish center
    Rubio-Martinez, A.
    Agustin, M. J.
    Recasens, V.
    Lopez-Gomez, L.
    Perella, M.
    Perez-Lungmus, G.
    Baringo, T.
    Giraldo, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 418 - 418
  • [9] Previous fludarabine treatment is a strong predictor for long-term cytopenia in non-Hodgkin lymphoma (NHL) patients treated with Y-90 ibritumomab tiuxetan
    Bentzen, H.
    Bach, B.
    Larsen, H.
    Pulczynski, S.
    Peterslund, N.
    Christiansen, I.
    Frederiksen, M.
    D'Amore, F.
    ANNALS OF ONCOLOGY, 2008, 19 : 245 - 245
  • [10] Phase I trial of yttrium 90 ibritumomab tiuxetan (90Y-RIT) with autologous stem cell transplantation (ASCT) in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL)
    Swinnen, L. J.
    Flinn, I. W.
    Kahl, B. S.
    Frey, E.
    Rogers, K.
    Jung, M.
    Jacene, H.
    Wahl, R. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345